The American company Moderna is facing problems with the production of its vaccine in Europe, which could lead to supply disruptions, Report informs, citing The Guardian.
Supply delays may affect the UK, Canada, and several other countries.
"The vaccine production process is a very complex process ... Despite our best efforts, we have not been able to implement the original production plan," the company said.